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We assessed the correlation between quantitative results of immunological faecal occult blood testing (I-FOBT) and colonic lesions
(191 colorectal cancers, 890 adenomas) detected at colonoscopy in 2597 FOBTþ (cutoff 100ngml
 1 Hb) subjects. At univariate
analysis, a higher average faecal Hb content was significantly associated with male gender (P¼0.003), age (P¼0.02), and
colonoscopy findings (P¼0.000). Among adenomas, higher faecal Hb content was significantly associated with size (P¼0.0000),
presence of severe dysplasia (P¼0.0001), presence of villous component (P¼0.0002), and location in the left colon (P¼0.003). At
multivariate analysis adjusting for potential confounders, age (P¼0.03), size (P¼0.0000), and location in the left colon (P¼0.0005)
were confirmed as having an independent association with higher faecal Hb content. Immunological FOBT is confirmed to be a
specific screening test to detect cancer and adenoma, with a low positivity rate (3.7%) and a high positive predictive value (41.5%).
Faecal Hb content is significantly higher for those lesions (cancer and high-risk adenomas) screening is aimed at detecting.
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Screening by faecal occult blood testing (FOBT) has been shown to
be effective in reducing colorectal cancer (CRC) mortality (Mandel
et al, 1993; Selby et al, 1993; Saito et al, 1995; Hardcastle et al, 1996;
Kronborg et al, 1996; Castiglione et al, 1997; Bertario et al, 1999;
Mandel et al, 2000), and population-based screening is currently
recommended by the European Community (Advisory Committee
on Cancer Prevention, 2000) and is under implementation in
several countries, including Italy (Zorzi et al, 2006) (www.
osservatorionazionalescreening.it).
Screening efficacy was demonstrated for guaiac-based FOBT,
but the high diagnostic performance of immunological FOBT
assays (I-FOBT) has recently justified their adoption in current
screening practice (Saito et al, 1995; Bertario et al, 1999). The
Florence FOBT population-based screening programme, run by
the Centro per lo Studio e la Prevenzione Oncologica (CSPO) since
1982, was confirmed to be effective by means of a case–control
study (Zappa et al, 1997): adjusted odds ratio for death from CRC
for screened vs not screened subjects was 0.60 (95% CI: 0.4–0.9).
The programme shifted from guaiac to I-FOBT in 1995, after
favourable comparison studies with guaiac FOBT (Castiglione
et al, 1996, 1997, 2000) and positivity cutoff was set at a
100ngml
 1 Hb level (Castiglione et al, 2002).
Faecal occult blood testing screening has often been criticised
for its limited specificity, Spurious guaiac-based FOBT positivity
has not been eliminated with the introduction of I-FOBT, owing to
non-neoplastic intestinal bleeding, and the efficacy of FOBT
screening has been claimed to be, at least partially, the effect of
a large cumulative use of colonoscopy, prompted by spurious
FOBT positivity at repeat screening (Lang and Ransohoff, 1994;
Ederer et al, 1997).
The use of quantitative I-FOBT allows for a precise assessment
of faecal Hb content and for assessing the association of Hb
content to different types of screen-detected colonic lesions. The
aim of the present study was to review a large consecutive series of
subjects with positive I-FOBT undergoing diagnostic assessment
within the Florence screening programme, in order to assess
whether I-FOBT positivity is mostly non-neoplastic and just offers
a chance for a screening colonoscopy, or if abnormal Hb content is
specifically associated to the presence of CRC and high-risk
adenomas.
MATERIALS AND METHODS
The study analyses a consecutive series of FOBTþ subjects,
invited and complying to diagnostic assessment in the Florence
screening programme for colorectal cancer. The detailed features
of the screening programme, inviting residents in the 50–70 years
age group to biennial FOBT, have been described elsewhere
(Castiglione et al, 1996, 2000; Zappa et al, 1997).
A single sampling on a single bowel movement is currently
analysed, without any dietary restriction. Immunological faecal
occult blood testing used in the study was OC-Hemodia, developed
with the OC-Sensor (Eiken Chemical Co, Japan) instrument. The
assays is based on the flocculation reaction between human HbA
and multiple monoclonal anti-HbA latex-adsorbed antibodies.
HbA concentration is measured by reading flocculation as an
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soptical change (increased adsorbance at 660nm), compared to a
standard calibration curve. The inter-series coefficient of variation
in our lab was 3.3% (15675.2) at a low and 3.8% at a high
(601722.9) Hb level.
The current positivity cutoff prompting diagnostic assessment
was 100ngml
 1 Hb. From December 1996 to September 2005,
screened FOBTþ subjects were 3029 of 81047 (3.73%). Com-
pliance to diagnostic assessment in the study period was 85.7%
(2597 of 3029). Assessment was based on total colonoscopy, or on
incomplete colonoscopy plus double contrast X-ray for those
subjects in whom total colonoscopy was not possible. Subjects with
negative colonoscopy were re-invited to screening after 5 years
until 2004 and after 10 years thereafter.
Data available for each case were age and gender, quantitative
FOBT Hb content (ngml
 l), and colonoscopy outcome (cancer,
adenoma, other benign lesion, negative). In subjects with multiple
findings (e.g. other benign lesionsþadenoma, adenomaþCRC),
only the most severe lesion was considered for the study purpose.
Adenomas were further categorised by size (o1, 1–2, 42cm),
presence/absence of severe dysplasia, histological features (tubu-
lar, villous), and site (right/trasverse or left colon): in presence of
multiple adenomas, the larger and/or that with the most severe
features were considered for the study purpose.
We assessed average FOBT Hb content (ngml
 l) by age and
gender, by colonoscopy outcome, and according to special
conditions (presence of haemorroids, diverticula) which might
be associated to non-neoplastic bleeding and were considered
separately from colonoscopy outcome. Average FOBT Hb content
was also determined by adenoma subcategories.
Differences between observed results were checked by the w
2
test, differences between means were checked by the t-test and
analysis of variance (ANOVA), while Mantel–Haenszel test was
used to check counfounding effects. A logarithmic transformation
of Hb values was performed, as the Hb histogram was not normally
distributed. Statistical significance was set at a Po0.05 level. The
STATA8 statistical package was used.
RESULTS
Overall, 2597 FOBTþ subjects (1109 women, 1488 men) were
assessed by colonoscopy from December 1996 to September 2005,
and were eligible for the study. Age ranged from 48 to 76 years
(median age¼62). Complete colonoscopy rate in the study period
was 82.2% (2137 of 2597).
Colonoscopy detected CRC in 191 subjects (7.3%), adenoma in
890 (34.2%), benign lesion other than adenoma in 985 (37.9%), and
was negative in 531 subjects (20.4%). A significantly higher
detection rate was observed in men as compared to women for
both CRC (8.5 vs 5.7%, w
2
df¼1¼7.12, P¼0.008) and adenoma (39.7
vs 26.8%, w
2
df¼1¼47.04, P¼10
 6). Increasing age was significantly
correlated to CRC (w
2 for trenddf¼1¼6.23, P¼0.01) and adenoma
(w
2 for trenddf¼1¼5.23, P¼0.02) detection rate. The presence of
haemorroids was recorded in 742 subjects (28.5%) and that of
diverticula in 598 subjects (23.0%).
Table 1 shows average Hb content observed in studied subjects
according to patient characteristics and most severe colonoscopy
outcome. Significant differences were observed by gender
(P¼0.003, t¼ 2.90, df¼2595) and age (P¼0.02, F¼2.75,
df¼4, 2592), with a peak in the 60–64 years age group. A trend
of increasing average Hb content was evident according to
colonoscopy outcome, from negative, through benign or adenoma,
to CRC findings. Differences were statistically significant (ANOVA,
P¼0.000, F¼83.42, df¼3, 2593). Average FOBT Hb content was
higher for cancers located in the left (N¼135) as compared with
right colon (N¼50, data missing in six cases), but the difference
did not reach statistical significance (816.3 vs 769.0ngml
 1,
P¼0.98, t¼0.01, df¼183). Out of 890 subjects with adenomas
as the unique or most severe lesion, 744 adenomas were detected in
the left, and 135 in the right colon (data was missing in 11 cases).
Maximum size was o1cm in 341, 1–2cm in 279, and 42cm in
270 cases. Severe dysplasia was reported in 175, and villous
component, in 487 cases. A substantial association was evident
between adenoma subcategories, severe dysplasia being
associated with size (o1cm¼6.7%, 1–2cm¼17.9%,
42cm¼37.7%, w
2
df¼2¼92.64, P¼10
 6), and increasing size
being associated with villous component (o1cm¼32.5%, 1–
2cm¼56.2%, 42cm¼81.1%, w
2
df¼2¼143.80, P¼10
 6). Associa-
tion between severe dysplasia and villous component
(tubular¼6.9%, villous¼30.1%) was apparent, owing to the
confounding effect of size (Mantel–Haenszel test, w
2
df¼1¼33.33,
P¼0.000). When adenoma were classified as advanced (larger
than 9mm, or with villous or tubulo-villous histological pattern
Table 1 Average FOBT Hb content observed in studied subjects according to patient characteristics and colonoscopy outcome
Variable Category Average FOBT Hb content (ngm
 l) s.d. Total cases P-value (t test/ANOVA)
Gender Male 466.0 494.6 1488 0.003
Female 438.8 631.7 1109
Age (years) 48–54 404.2 587.9 463 0.02
55–59 473.3 546.8 525
60–64 497.3 644.9 681
65–69 438.2 476.0 730
70–76 433.4 445.9 198
Diagnostic assessment outcome (most severe lesion)
Cancer — 817.0 645.2 191 0.000
Adenoma Any 509.2 528.6 890
Benign, other — 407.5 610.7 985
Negative — 319.0 369.1 531
Haemorroids Present 439.6 695.8 742 0.002
Absent 460.3 491.3 1855
Diverticula Present 475.6 628.4 598 0.688
Absent 448.0 534.2 1999
ANOVA¼analysis of variance; FOBT¼faecal occult blood testing; Hb¼haemoglobin.
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s(420%), or with high-grade dysplasia) or not advanced, Hb
content was significantly higher for advanced adenomas (N¼669,
average 550ngml
 1, median 356ngml
 1) as compared with not
advanced ones (N¼221, average 385ngml
 1, median
222ngml
 1). Larger adenomas were observed in the left as
compared with right colon (w
2
df¼2¼6.27, P¼0.04) (data not
shown). Apart from colonoscopy outcome, no positive association
with higher Hb content was observed for the presence of
haemorroids or diverticula.
Table 2 shows differences in FOBT Hb content according to
adenoma subcategories. A significant positive association was
evident for increasing size (P¼0.0000, F¼31.58, df¼2887),
presence of severe dysplasia (P¼0.0001, t¼ 3.84, df¼888),
and presence of villous component (P¼0.0002, t¼ 3.78,
df¼888). Weaker association was recorded for left vs right colon
site (P¼0.0037, t¼2.90, df¼877).
Table 3 shows multivariate analysis of the association of different
patient characteristics and colonoscopy outcome to average FOBT
Hb content among subjects with adenoma. A significant association
was evident only for adenoma size (P¼0.000) and for localisation in
left colon (P¼0.01), and a borderline association was observed for
age (P¼0.05). After adjusting for interactions, results did not
change. The model was thus limited to variables with significant
association, and age (P¼0.03, F¼2.63, df¼4871), size (P¼0.0000,
F¼29.29, df¼2, 871), and location in the left colon (P¼0.005,
F¼7.76, df¼1871) were confirmed as having an independent
association with FOBT Hb content.
DISCUSSION
The present study is based on a relatively large consecutive series,
observed within a single population-based screening programme,
and followed up according to the same protocol. Immunological-
FOBT was based on the same assay over the study period, and
processed by a single laboratory: these conditions allow for a
reliable estimate of the association of faecal Hb content to the
presence of colonic lesions in I-FOBTþ subjects undergoing
colonoscopy assessment.
Immunological-FOBT proved to be a rather specific test, with a
41.5% PPV for the presence of CRC or adenoma among assessed
subjects, definitely a higher figure as compared to other cancer
screening programmes, such as mammographic or cytological
screening, where the PPV of a positive screening test does not
currently exceed 20%. It is implied that such a high PPV is at least
partially due to the exit from screening of bleeders with benign
disease undergoing negative colonoscopy, but other reasons, such
as a selection of high-risk subjects among screening compliers,
cannot be excluded.
Increased faecal Hb content was significantly associated with
increasingly severe colonic lesions, confirming previous reports on
this subject (Edwards, 2005; Vilkin et al, 2005). A continuous trend
of increasing Hb content was evident, from subjects with negative
colonoscopy outcome, to subjects with benign colonic abnormal-
ities other than adenoma, to subjects with adenoma as the most
severe lesion, and finally to subjects with CRC. Among subjects
with adenoma, faecal Hb content was higher for high-risk
subcategories, such as larger size, presence of severe dyplasia or
villous component. To our knowledge, this is the first study
reporting the association of faecal Hb content to single adenoma
characteristics, whereas previous studies grouped adenomas into
low- and high-risk categories (Edwards, 2005; Vilkin et al, 2005).
The higher average faecal Hb content recorded for adenomas in
the left colon may be likely explained with a higher mechanical
action of stool in this section.
Multivariate analysis confirmed an independent and significant
association with higher faecal Hb content for patient’s age,
adenoma location in the left colon, and adenoma size, the latter
variable showing the strongest association. This, combined with
the association of Hb content with adenoma characteristics, and
with the adoption of a 100ngml
 1 Hb positivity threshold, allowed
for a favourable advanced/not advanced adenoma ratio of
approximately 3:1 (669/221), as compared to approximately 1:1
when guaiac FOBT was employed (Castiglione, 1996).
Immunological-FOBT positivity rate in the present experience
was 3.73%. Positivity rate owing to non-neoplastic bleeding
is likely to be reduced at repeat screening, as I-FOBTþ colono-
scopy negative subjects, who may have a tendency for persistent
spurious intestinal bleeding, exit the screening process (for 10
years in the Florence screening programme). Thus, biennial I-
FOBT screening from 50 to 70 years of age would imply
approximately 20–30% of screened subjects being I-FOBTþ and
Table 2 Average FOBT Hb content observed in studied subjects with adenoma as the most severe lesion according to different subcategories (when
multiple, only the adenoma largest in size or with most severe features was considered)
Variable Category Average FOBT Hb content (ngm
 l) s.d. Total cases P-value (t test/ANOVA)
Size (cm) o1 406.9 489.0 341 0.000
1–2 486.0 476.5 279
42 662.4 590.9 270
Severe dysplasia Present 615.0 544.1 175 0.0001
Absent 483.3 521.9 715
Histological type Villous 559.8 544.2 487 0.0002
Tubular 448.0 503.0 403
Site (colon) Left 520.5 505.9 744 0.0037
Right 448.2 639.1 135
ANOVA¼analysis of variance; FOBT¼faecal occult blood testing; Hb¼haemoglobin.
Table 3 Results of multivariate analysis (ANOVA) of the association of
different patient characteristics and colonoscopy outcome to average
FOBT Hb content among subjects with adenoma
Source df F P-value
Model 12 6.77 0.000
Age (48–54, 55–59, 60–64, 65–69, 70–76 years) 4 2.34 0.05
Gender (male vs female) 1 0.35 0.55
Largest adenoma size (o1, 1–2, 42cm) 2 19.84 0.000
Presence of adenoma with severe dysplasia 1 0.60 0.43
Presence of adenoma with villous component 1 0.30 0.58
Adenoma localisation (left vs right colon) 1 6.65 0.01
Presence of haemorroids 1 0.07 0.79
Presence of diverticula 1 0.59 0.44
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sinvited to undergo colonoscopy over a 20 years period. When
such figures are compared to a 20% intention-to-screen-based
mortality reduction reported by FOBT screening trials, the
hypothesis of FOBT screening being effective only through
colonoscopies recommended for spurious FOBT positivity is
hardly acceptable.
Our findings show that I-FOBT is a specific screening test to
detect CRC and adenoma. Immunological-FOBT is associated with
a relatively low (3.73%) positivity rate, with a rather high (41.5%)
positive predictive value for colonic neoplasms, and faecal Hb
content is significantly related to the presence of those lesions
(CRC and high-risk adenomas) screening is aimed at detecting.
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